Microbiome Drug is a kind of medicine made with microorganisms. According to the source, it is divided into three categories: drugs derived from whole or part of microorganisms, drugs derived from microbial primary metabolites, and drugs derived from microbial secondary metabolites.
This report contains market size and forecasts of Microbiome Drugs in Global, including the following market information:
Global Microbiome Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Microbiome Drugs market was valued at 228.4 million in 2021 and is projected to reach US$ 1691.5 million by 2028, at a CAGR of 33.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Dosage Form Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microbiome Drugs include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Microbiome Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microbiome Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Microbiome Drugs Market Segment Percentages, by Type, 2021 (%)
Oral Dosage Form
Enteric Capsules
Global Microbiome Drugs Market, by Symptom, 2017-2022, 2023-2028 ($ millions)
Global Microbiome Drugs Market Segment Percentages, by Symptom, 2021 (%)
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Global Microbiome Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Microbiome Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microbiome Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Microbiome Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel

LEAVE A REPLY

Please enter your comment!
Please enter your name here